Adenocarcinoma Doctors Abroad — Page 3

Professor Saban Sec is a leading specialist representative for the Turkish Medical Oncology Association, focusing on high-risk adenocarcinoma cases at Valued Med Hub Hospitals.

• Specialises in gastrointestinal cancers, including colon, rectum, liver, and stomach adenocarcinomas
• Researched BRCA mutation profiles to improve treatment for high-risk breast cancer patients
• Uses perioperative FLOT protocols – intensive chemotherapy to shrink tumours before and after surgery
• Expert in managing HER2-positive metastatic gastric cancer and rare salvary gland tumours
• Evaluates metabolic tumour volume to predict how patients will respond to chemotherapy

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a decade of documented research into gastrointestinal and neuroendocrine tumours.

• Specialises in systemic therapy for internal organ adenocarcinomas and neuroendocrine tumours
• Former researcher at Istanbul University's Cerrahpasa Medical Faculty focusing on complex oncology cases
• Published findings on managing gastrointestinal cancers in major international journals like Medical Oncology
• Expertise in identifying paraneoplastic syndromes, helping manage rare side effects of cancer and its treatment

Professor Bunyamin Kaplan is a senior specialist in radiation oncology at Medipol Mega University Hospital – one of Turkey's largest private medical facilities.

• Specialises in precise radiation therapy to target cancer while sparing healthy tissue
• Coordinates multi-disciplinary care alongside surgeons and medical oncologists
• Expert in managing cancer at different stages using focused radiation protocols
• Trains other specialists as a Professor within the university hospital system

Associate Professor Tahsin Ozatli is a senior oncologist at Istinye University Liv Hospital who focuses on gastrointestinal and lung malignancies.

• Specialises in managing adenocarcinoma of the lung and digestive tract
• Previously served at the Ankara Oncology Clinic – one of the region's major cancer centres
• Trained at Selcuk University before earning his Associate Professor title
• Broad expertise in internal medicine allows for better management of treatment side effects

Education

Ondokuz Mayıs University Faculty of Medicine (1991)

KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

Associate Professor Nail Paksoy is an ESMO board-certified medical oncologist specialising in targeted therapies and international clinical trials for gastrointestinal and lung cancers.

• Participated in global trials for advanced adenocarcinoma, including the NAVIGATE and RECITE studies
• Completed a specialised fellowship at the Istanbul University Oncology Institute
• Uses PRRT therapy – a targeted radiation treatment for metastatic neuroendocrine tumours
• Expert in the FLOT regimen, an effective chemotherapy protocol for gastric adenocarcinoma
• Board certified by the European Society for Medical Oncology (ESMO)

Professor Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya Hospital Complex. He focuses on tailored drug therapies for adenocarcinoma cases.

• Specialises in medical oncology – uses targeted drug treatments to manage internal tumours
• Trained at Akdeniz University – one of Turkey's premier medical research institutions
• Manages complex cases within a multidisciplinary oncology framework
• Focuses on precise dosing and modern systemic therapy protocols

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.